BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 29072704)

  • 1. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.
    Hao F; Cubero FJ; Ramadori P; Liao L; Haas U; Lambertz D; Sonntag R; Bangen JM; Gassler N; Hoss M; Streetz KL; Reissing J; Zimmermann HW; Trautwein C; Liedtke C; Nevzorova YA
    Cell Death Dis; 2017 Oct; 8(10):e3152. PubMed ID: 29072704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
    Im KH; Saeed WK; Kim EB; Lee AH; Kim JE; Lee SM; Hanning X; Kim HS; Jun DW; Yoon EL
    Dig Dis Sci; 2024 May; 69(5):1701-1713. PubMed ID: 38551744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.
    Ramadori P; Woitok MM; Estévez-Vázquez O; Benedé-Ubieto R; Leal-Lassalle H; Lamas-Paz A; Guo F; Fabre J; Otto J; Verwaayen A; Reissing J; Bruns T; Erschfeld S; Haas U; Paffen D; Nelson LJ; Vaquero J; Bañares R; Trautwein C; Cubero FJ; Liedtke C; Nevzorova YA
    Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166646. PubMed ID: 36736843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation.
    Roychowdhury S; Chiang DJ; Mandal P; McMullen MR; Liu X; Cohen JI; Pollard J; Feldstein AE; Nagy LE
    Alcohol Clin Exp Res; 2012 Jul; 36(7):1139-47. PubMed ID: 22273278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis.
    Cubero FJ; Peng J; Liao L; Su H; Zhao G; Zoubek ME; Macías-Rodríguez R; Ruiz-Margain A; Reißing J; Zimmermann HW; Gassler N; Luedde T; Liedtke C; Hatting M; Trautwein C
    J Hepatol; 2018 Dec; 69(6):1326-1334. PubMed ID: 30144553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
    Liedtke C; Bangen JM; Freimuth J; Beraza N; Lambertz D; Cubero FJ; Hatting M; Karlmark KR; Streetz KL; Krombach GA; Tacke F; Gassler N; Riethmacher D; Trautwein C
    Gastroenterology; 2011 Dec; 141(6):2176-87. PubMed ID: 21878202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents.
    Hatting M; Zhao G; Schumacher F; Sellge G; Al Masaoudi M; Gaβler N; Boekschoten M; Müller M; Liedtke C; Cubero FJ; Trautwein C
    Hepatology; 2013 Jun; 57(6):2189-201. PubMed ID: 23339067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
    Apte UM; McRee R; Ramaiah SK
    Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice.
    Chaudhary K; Liedtke C; Wertenbruch S; Trautwein C; Streetz KL
    J Hepatol; 2013 Dec; 59(6):1292-8. PubMed ID: 23928400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.
    Marin V; Poulsen K; Odena G; McMullen MR; Altamirano J; Sancho-Bru P; Tiribelli C; Caballeria J; Rosso N; Bataller R; Nagy LE
    J Hepatol; 2017 Nov; 67(5):1018-1025. PubMed ID: 28647568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice.
    Bhopale KK; Amer SM; Kaphalia L; Soman KV; Wiktorowicz JE; Shakeel Ansari GA; Kaphalia BS
    Alcohol Clin Exp Res; 2017 Oct; 41(10):1675-1685. PubMed ID: 28792616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Fisetin Supplementation Protects Against Alcohol-Induced Liver Injury in Mice.
    Sun Q; Zhang W; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2076-2084. PubMed ID: 27575873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease.
    Nevzorova YA; Cubero FJ; Hu W; Hao F; Haas U; Ramadori P; Gassler N; Hoss M; Strnad P; Zimmermann HW; Tacke F; Trautwein C; Liedtke C
    J Hepatol; 2016 Mar; 64(3):628-40. PubMed ID: 26576483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice.
    Bhopale KK; Wu H; Boor PJ; Popov VL; Ansari GA; Kaphalia BS
    Alcohol; 2006 Jul; 39(3):179-88. PubMed ID: 17127137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice.
    Warner DR; Warner JB; Hardesty JE; Song YL; Chen CY; Chen Z; Kang JX; McClain CJ; Kirpich IA
    FASEB J; 2021 Feb; 35(2):e21377. PubMed ID: 33481293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.